Science Versus the Biological Clock at the 2007 Aspen Health Forum with discussants William Colby, Cynthia Kenyon and Stephanie Lederman. Nigel Cameron moderates the discussion.
Despite advances in medical research, we're all getting older - but that hasn't stopped the scientific search for the Fountain of Youth. Experts such as those on our panel are discovering genes central to the aging process. Their research may make it possible to slow the process of aging, but in the meantime we face a burgeoning population of older adults. This demographic shift has the potential to change medical research, health care, and our nation as a whole- Aspen Institute
William Colby is a Senior Fellow with the National Hospice and Palliative Care Organization in Washington, D.C. He is also the lawyer who represented the family of Nancy Cruzan in their family's right-to-die case, the first such case heard by the U.S. Supreme Court.
Mr. Colby has been interviewed on Larry King Live, CNN, MSNBC, Hardball, Fox News, Good Morning America, NPR, Today, CBS This Morning, and similar programs, and speaks across the country on the issues we face at the end of life. He has written on these topics for USA Today, Kansas City Star, Philadelphia Inquirer and other publications.
His most recent book, Unplugged: Reclaiming Our Right to Die in America, was released in the summer of 2006. He graduated from the University of Kansas School of Law, clerked on the U.S. Court of Appeals for the D.C. Circuit and practiced law in Washington, D.C. and Kansas City.
Cynthia Kenyon is an American Cancer Society Professor and Director of the Hillblom Center for the Biology of Aging at the University of California, San Francisco. Dr. Kenyon is widely known for her pioneering research in the tiny worm called Caenorhabditis elegans, or C. elegans for short, which showed that changes to a single gene could double the worm's lifespan.
Her work sparked an intensive study of the molecular biology of aging and led to the discovery that an evolutionarily protected hormone signaling system controls aging in other organisms as well, including mammals. She has taught at UCSF since 1986, and prior to that conducted postdoctoral studies with Nobel laureate Sydney Brenner at the MRC Laboratory of Molecular Biology in Cambridge, England, where she first began working with C. elegans.
Dr. Kenyon has received many awards for her research. She obtained her PhD from the Massachusetts Institute of Technology.
Stephanie Lederman is Executive Director of the American Federation for Aging Research (AFAR), a leading, not-for-profit organization supporting biomedical research on aging. Under Ms. Lederman's leadership over the past 15 years, AFAR has grown into an organization that has been able to contribute nearly 93 million dollars to more than 2,200 new investigators and students conducting biomedical research on the aging process and age-related diseases.
During the course of her career in the not-for-profit sector, Ms. Lederman has served as executive director of The Children's Health Fund and The National Center for Health Education. She also has held leadership positions at The American Red Cross in Greater New York, Memorial Sloan-Kettering Cancer Center and The American Heart Association. She holds a master's degree from Boston University. She is a Fellow of the New York Academy of Medicine and a member of the New York Academy of Sciences.
Nigel M. de S. Cameron
Nigel M. de S. Cameron is President of the Institute on Biotechnology and the Human Future, Director of the Center on Nanotechnology and Society, Research Professor of Bioethics and Associate Dean at Chicago-Kent College of Law in the Illinois Institute of Technology.
Cameron founded the journal Ethics and Medicine in 1983 and is widely recognized as a commentator on bioethics and biotech policy issues with appearances on ABC Nightline, CNN, PBS Frontline, and the BBC. His books include The New Medicine: Life and Death After Hippocrates and Nanoscale: Issues and Perspectives for the Nano Century (edited, forthcoming).
He has been a visiting scholar at UBS Wolfsberg in Switzerland, a featured speaker at the Aspen Ideas Festival, and a participant in the US/European Commission dialogue on Perspectives on the Future of Science and Technology. He has also represented the United States as bioethics advisor on US delegations to the United Nations, and is currently a member of the United States National Commission on UNESCO. A native of the United Kingdom, he has studied at Cambridge and Edinburgh universities and the Edinburgh Business School.